GSK’s Benlysta Approved to Treat Active Lupus Nephritis

GlaxoSmithKline has received FDA approval for Benlysta (belimumab) to treat active lupus nephritis, a serious inflammation of the kidneys that appears in about four in 10 patients with the most common form of lupus. The inflammation can lead to end-stage kidney disease, requiring dialysis or a kidney transplant. Source: Drug Industry Daily

Read More

Sackler Family, Current Purdue CEO Condemned in House Oversight Hearing

In a Thursday hearing of a congressional committee, two members of the Sackler family and Purdue Pharma’s current president and CEO, Craig Landau, dutifully expressed sorrow for the role played by Purdue’s former flagship product, the painkiller OxyContin (oxycodone), in the opioid abuse crisis that has killed thousands of Americans. Source: Drug Industry Daily

Read More

MedTech Europe: Class D Diagnostics Vulnerable Under EU IVDR

The EU’s implementation of the new In Vitro Medical Device Regulation (IVDR) “has ground to a halt in the wake of the COVID-19 outbreak,” MedTech Europe said, pressing the European Commission for help with the transition process for high-risk devices. Source: The GMP Letter

Read More